Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors.

Cathepsin D, a lysosomal protease, is overexpressed in primary breast cancer and associated with increased risk of metastasis. We have shown previously by transfection in rat tumor cells that overexpression of cathepsin D increased both experimental metastasis in nude mice and in vitro proliferation under low-serum conditions. In this study, we used the transfected cell lines to investigate the mechanism by which cathepsin D prevents density-dependent arrest of cell proliferation. This effect was not associated with a general alteration of cell-substratum or cell-cell adhesiveness. As shown by coculture and conditioned media experiments, control cells reaching saturation density released inhibitory activity that was able to prevent the growth of control or cathepsin D transfectants and decreased the cloning efficiency of normal rat kidney fibroblasts in agar. By contrast, in media from two cathepsin D-transfected cell lines, this inhibitory activity was markedly reduced. Cathepsin D overexpression did not affect cell sensitivity to the inhibitor but modified the secretion of several proteins. The increase in cell density appeared to be due to intracellular maturation of cathepsin D since it was reversed by amine treatment that neutralizes the pH of acidic compartments within the cells. Moreover, the addition of secreted pro-cathepsin D was unable to increase the saturation density of control clones. Finally, the inhibitory factor was partially characterized as a heat-labile, secreted protein. We conclude that cathepsin D overexpression increases the growth of cancer cells to a higher density via an intracellular mechanism, leading to a decreased secretion of growth inhibitor(s).

[1]  H. Rochefort,et al.  Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. , 1994, Experimental cell research.

[2]  H. Rochefort,et al.  Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. , 1994, Journal of cell science.

[3]  H. Rochefort,et al.  Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal. , 1994, Oncogene.

[4]  B. Zetter,et al.  Adhesion molecules in tumor metastasis. , 1993, Seminars in cancer biology.

[5]  T. Maudelonde,et al.  Immunoradiometric assay of pro-cathepsin D in breast cancer cytosol: relative prognostic value versus total cathepsin D. , 1993, European journal of cancer.

[6]  H. Rochefort,et al.  Cathepsin D in breast cancer: a tissue marker associated with metastasis. , 1992, European journal of cancer.

[7]  宮地 幸隆 Immunoradiometric assay--最近の進歩と問題点 , 1991 .

[8]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[9]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[10]  L. Lund,et al.  The urokinase receptor and regulation of cell surface plasminogen activation. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.

[11]  P. Pujol,et al.  Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. , 1990, Oncogene.

[12]  H. Rochefort,et al.  Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. , 1990, Cancer research.

[13]  M. Kaminski,et al.  Production of mammastatin, a tissue-specific growth inhibitor, by normal human mammary cells. , 1989, Science.

[14]  P. Bédard,et al.  Rapid repression of quiescence-specific gene expression by epidermal growth factor, insulin, and pp60v-src , 1989, Molecular and cellular biology.

[15]  Lennart Philipson,et al.  Genes specifically expressed at growth arrest of mammalian cells , 1988, Cell.

[16]  Marcel Garcia,et al.  Estrogen‐induced lysosomal proteases secreted by breast cancer cells: A role in carcinogenesis? , 1987, Journal of cellular biochemistry.

[17]  W. Rutter,et al.  Insulin-like growth factor II receptor as a multifunctional binding protein , 1987, Nature.

[18]  P. Ferrara,et al.  Purification and first characterization of the secreted and cellular 52-kDa proteins regulated by estrogens in human-breast cancer cells. , 1986, European journal of biochemistry.

[19]  G. Todaro,et al.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Donahoe,et al.  Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells , 1986, Cell.

[21]  H. Rochefort,et al.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.

[22]  D. Goeddel,et al.  Expression of human immune interferon cDNA in E. coli and monkey cells , 1982, Nature.

[23]  G. Todaro,et al.  Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation , 1978, Journal of cellular physiology.

[24]  D. Carney,et al.  Initiation of chick cell division by trypsin action at the cell surface , 1977, Nature.

[25]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[26]  H. Schnebli,et al.  Selective inhibition of growth of transformed cells by protease inhibitors. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Rubin,et al.  Release from Density Dependent Growth Inhibition by Proteolytic Enzymes , 1970, Nature.

[28]  M. Burger Proteolytic Enzymes Initiating Cell Division and Escape from Contact Inhibition of Growth , 1970, Nature.